PortfoliosLab logoPortfoliosLab logo
ARA.TO vs. ASND
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ARA.TO vs. ASND - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Aclara Resources Inc. (ARA.TO) and Ascendis Pharma A/S (ASND). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

ARA.TO is traded in CAD, while ASND is traded in USD. To make them comparable, the ASND values have been converted to CAD using the latest available exchange rates.

Returns By Period

In the year-to-date period, ARA.TO achieves a 113.89% return, which is significantly higher than ASND's 2.96% return.


ARA.TO

1D
-3.75%
1M
-1.91%
YTD
113.89%
6M
72.39%
1Y
477.50%
3Y*
114.21%
5Y*
10Y*

ASND

1D
0.50%
1M
-3.32%
YTD
2.96%
6M
7.71%
1Y
25.91%
3Y*
34.96%
5Y*
13.87%
10Y*
33.94%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARA.TO vs. ASND - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ARA.TO
Aclara Resources Inc.
113.89%380.00%-10.00%56.25%-77.78%-10.00%
ASND
Ascendis Pharma A/S
2.96%47.79%18.70%0.86%-2.75%-4.52%

Correlation

The correlation between ARA.TO and ASND is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.05

Correlation (All Time)
Calculated using the full available price history since Dec 13, 2021

0.05

Fundamentals

Market Cap

ARA.TO:

CA$1.02B

ASND:

$13.99B

EPS

ARA.TO:

-CA$0.05

ASND:

$8.08

PB Ratio

ARA.TO:

6.71

ASND:

28.64

Total Revenue (TTM)

ARA.TO:

CA$0.00

ASND:

$867.51M

Gross Profit (TTM)

ARA.TO:

-CA$1.03M

ASND:

$764.89M

EBITDA (TTM)

ARA.TO:

-CA$9.35M

ASND:

-$6.94M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ARA.TO vs. ASND — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARA.TO
ARA.TO Risk / Return Rank: 9595
Overall Rank
ARA.TO Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
ARA.TO Sortino Ratio Rank: 9393
Sortino Ratio Rank
ARA.TO Omega Ratio Rank: 9191
Omega Ratio Rank
ARA.TO Calmar Ratio Rank: 9797
Calmar Ratio Rank
ARA.TO Martin Ratio Rank: 9595
Martin Ratio Rank

ASND
ASND Risk / Return Rank: 6565
Overall Rank
ASND Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
ASND Sortino Ratio Rank: 5858
Sortino Ratio Rank
ASND Omega Ratio Rank: 5555
Omega Ratio Rank
ASND Calmar Ratio Rank: 7373
Calmar Ratio Rank
ASND Martin Ratio Rank: 7474
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARA.TO vs. ASND - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aclara Resources Inc. (ARA.TO) and Ascendis Pharma A/S (ASND). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ARA.TOASNDDifference
Sharpe ratioReturn per unit of total volatility

+3.55

Sortino ratioReturn per unit of downside risk

+2.54

Omega ratioGain probability vs. loss probability

1.46

1.15

+0.31

Calmar ratioReturn relative to maximum drawdown

8.93

2.05

+6.87

Martin ratioReturn relative to average drawdown

19.00

5.05

+13.94

ARA.TO vs. ASND - Sharpe Ratio Comparison

The current ARA.TO Sharpe Ratio is 4.27, which is higher than the ASND Sharpe Ratio of 0.72. The chart below compares the historical Sharpe Ratios of ARA.TO and ASND, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ARA.TOASNDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

4.27

0.72

+3.55

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.29

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.67

Sharpe Ratio (All Time)

Calculated using the full available price history

0.29

0.50

-0.21

Drawdowns

ARA.TO vs. ASND - Drawdown Comparison

The maximum ARA.TO drawdown since its inception was -84.38%, which is greater than ASND's maximum drawdown of -59.38%. Use the drawdown chart below to compare losses from any high point for ARA.TO and ASND.


Loading charts...

Drawdown Indicators


ARA.TOASNDDifference

Max Drawdown

Largest peak-to-trough decline

-84.38%

-59.38%

-25.00%

Max Drawdown (1Y)

Largest decline over 1 year

-53.93%

-12.84%

-41.09%

Max Drawdown (3Y)

Largest decline over 3 years

-53.93%

-28.80%

-25.13%

Max Drawdown (5Y)

Largest decline over 5 years

-57.34%

Max Drawdown (10Y)

Largest decline over 10 years

-59.38%

Current Drawdown

Current decline from peak

-11.49%

-12.41%

+0.92%

Average Drawdown

Average peak-to-trough decline

-57.30%

-17.58%

-39.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.30%

5.18%

+20.12%

Volatility

ARA.TO vs. ASND - Volatility Comparison

Aclara Resources Inc. (ARA.TO) has a higher volatility of 22.10% compared to Ascendis Pharma A/S (ASND) at 15.20%. This indicates that ARA.TO's price experiences larger fluctuations and is considered to be riskier than ASND based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ARA.TOASNDDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.10%

15.20%

+6.90%

Volatility (6M)

Calculated over the trailing 6-month period

63.37%

28.93%

+34.44%

Volatility (1Y)

Calculated over the trailing 1-year period

112.95%

36.67%

+76.28%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

91.27%

47.77%

+43.50%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

91.27%

50.77%

+40.50%

Dividends

ARA.TO vs. ASND - Dividend Comparison

Neither ARA.TO nor ASND has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ARA.TO vs. ASND - Financials Comparison

This section allows you to compare key financial metrics between Aclara Resources Inc. and Ascendis Pharma A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M202220232024202520260
250.66M
(ARA.TO) Total Revenue
(ASND) Total Revenue
Please note, different currencies. ARA.TO values in CAD, ASND values in USD

Frequently Asked Questions


ARA.TO and ASND have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for ARA.TO and ASND

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer